P4O2 ILD Extension

Abroad (travel likely)Recruiting

Conditions

Interstitial Lung Disease · Pulmonary Fibrosis · Interstitial Lung Fibrosis · IPF · Pulmonary Fibrosis, Idiopathic · Pulmonary Fibrosis Idiopathic Familial · Chronic Hypersensitivity Pneumonitis · Unclassifiable ILD · Idiopathic NSIP · CTD-ILD

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Amsterdam UMC, locatie VUmc, Amsterdam, North Holland, Netherlands
Contact: Study coordinator (Iris Simons, MD) · i.simons@amsterdamumc.nl

Study leads

Esther Nossent, MD
Principal Investigator
Amsterdam UMC, locatie VUmc
Jan Willem Duitman, PhD
Principal Investigator
Amsterdam UMC, locatie VUmc
Anke-Hilse Maitland-van der Zee, PhD
Principal Investigator
Amsterdam UMC, locatie VUmc

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Interstitial Lung Disease Research Unit Biobank

Interstitial Lung Disease · Sarcoidosis · Idiopathic Pulmonary Fibrosis

Abroad (travel likely)Recruiting

Kansas City, United States

FAPI PET for Lung Fibrosis

Interstitial Lung Disease · Idiopathic Interstitial Pneumonias · Drug-Induced Pneumonitis

Abroad (travel likely)RecruitingEARLY_PHASE1

Los Angeles, United States

Pulmonary Fibrosis Foundation Community Registry

Pulmonary Fibrosis · Interstitial Lung Disease · Lung Fibrosis

Abroad (travel likely)Recruiting

Chicago, United States

Role of Genetic Factors in the Development of Lung Disease

Cystic Fibrosis · Pulmonary Fibrosis · Tuberous Sclerosis

Abroad (travel likely)Recruiting

Bethesda, United States · Bethesda, United States